Literature DB >> 33196

High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man.

C Fischer, U Klotz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 33196     DOI: 10.1016/s0378-4347(00)81919-2

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  13 in total

1.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Pharmacokinetics of sulfasalazine metabolites in rats following concomitant oral administration of riboflavin.

Authors:  V S Chungi; L W Dittert; L Shargel
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

4.  Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.

Authors:  M E Sharp; S M Wallace; K W Hindmarsh; M A Brown
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.

Authors:  J M Day; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

6.  The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.

Authors:  W M Awni; R A Braeckman; C S Locke; L M Dubé; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 7.  The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.

Authors:  Ulrich Klotz
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 8.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

Review 9.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

10.  The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis.

Authors:  A J Taggart; B J McDermott; S D Roberts
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.